Risk factors and comorbidities in primary biliary cirrhosis: a controlled interview-based study of 1032 patients.
about
Primary biliary cirrhosisLiver involvement in subjects with rheumatic diseasePharmacological treatments for primary biliary cirrhosis: a network meta-analysisAntimitochondrial antibodies in acute liver failure: implications for primary biliary cirrhosisThe Autoimmune EcologyPrimary Biliary Cirrhosis and Primary Sclerosing Cholangitis: a Review Featuring a Women's Health PerspectiveLiver Transplantation for Patients with Cholestatic Liver DiseasesPrimary biliary cirrhosis: From bench to bedsideThe immunogenetics of primary biliary cirrhosis: A comprehensive reviewThe diagnosis of primary biliary cirrhosisThe X-factor in primary biliary cirrhosis: monosomy X and xenobioticsPrimary biliary cirrhosis and liver transplantationPrimary biliary cirrhosis: Pathophysiology, clinical presentation and therapyOrganic solvents as risk factor for autoimmune diseases: a systematic review and meta-analysisPrimary biliary cirrhosis: Clinical and laboratory criteria for its diagnosisPrimary biliary cirrhosis is a generalized autoimmune epithelitisClinical Characteristics of Concomitant Systemic Lupus Erythematosus and Primary Biliary Cirrhosis: A Literature ReviewRecent advances in the diagnosis and treatment of primary biliary cholangitis.Impact of Microbes on the Pathogenesis of Primary Biliary Cirrhosis (PBC) and Primary Sclerosing Cholangitis (PSC)Pulmonary Manifestations among Patients with Primary Biliary CirrhosisEpidemiology of environmental exposures and human autoimmune diseases: findings from a National Institute of Environmental Health Sciences Expert Panel WorkshopOccupational and environmental exposures and risk of systemic lupus erythematosus: silica, sunlight, solvents.Genomic variants associated with primary biliary cirrhosis.Common genetic variation and haplotypes of the anion exchanger SLC4A2 in primary biliary cirrhosis.Autoimmunity and environment: am I at risk?Challenge of liver disease in systemic lupus erythematosus: Clues for diagnosis and hints for pathogenesisPrimary biliary cirrhosis (PBC), PBC autoantibodies, and hepatic parameter abnormalities in a large population of systemic sclerosis patientsAn increased risk of urinary tract infection precedes development of primary biliary cirrhosisImpact of microbes on autoimmune diseases.Biliary apotopes and anti-mitochondrial antibodies activate innate immune responses in primary biliary cirrhosisDifferences between Caucasian, African American, and Hispanic patients with primary biliary cirrhosis in the United States.Update on the genetics and genomics of PBC.Biliary epithelial apoptosis, autophagy, and senescence in primary biliary cirrhosisAutoimmune hepatitis type 2 associated with an unexpected and transient presence of primary biliary cirrhosis-specific antimitochondrial antibodies: a case study and review of the literature.Primary biliary cirrhosis in a genetically homogeneous population: disease associations and familial occurrence rates.Ongoing activation of autoantigen-specific B cells in primary biliary cirrhosisRecent advances in the development of farnesoid X receptor agonistsThe autoimmunity of primary biliary cirrhosis and the clonal selection theory.High levels of soluble CTLA-4 are present in anti-mitochondrial antibody positive, but not in antibody negative patients with primary biliary cirrhosis.Environmental factors in primary biliary cirrhosis.
P2860
Q21202919-E6708B28-4BEB-4AF6-86F1-D8C350651DB4Q22000839-6A021265-63DF-4DE6-96B4-A3635B4CBBEFQ24186852-E2E58AA9-3BEC-4442-932A-3ADDAFE4249FQ24634370-C1355493-485A-4CA9-8815-37E0DB72570BQ26747427-97793BC9-3E9F-4213-A0B9-0E659297C58DQ26781780-ABB7A17E-B232-470A-8543-B64C3234BFC0Q26782863-63E47166-ACB6-407D-97F8-C81CD4B46360Q26799419-2522B8DD-98E7-4C77-8E02-9644E820B226Q26801377-1A7832AA-15B5-4AA8-BCFD-3FEFCBDEEBAFQ26829493-DE539E68-14CF-4D72-BB13-BDA76D73FF4CQ26830032-2B32C704-70D2-44A6-BC4F-10BE1FB21CC9Q26853145-40D0E44C-6658-42BA-A375-403038C18EB5Q26853649-387318A2-4A09-44B7-A5AE-D74BF3815C63Q26860327-D96CA41F-06F1-4184-A0AA-4A1FEA608AF8Q26992087-DC89856D-9692-43D0-A703-3EFB97CA1B6BQ27016114-16D5027C-0208-457D-A255-D5694F0A3C9BQ27691276-0ED66759-2CB2-4C98-902D-C30961DB86E6Q28076353-2705B3A3-7FBD-4730-B68B-03D8C9C8EAF7Q28076453-61A413E1-945C-40BE-A680-4F3080FF7DE8Q28078424-E1594121-A758-459B-B02D-76E48B518FB7Q28390922-1FBC1E11-586E-48BC-8F09-63590E8E262CQ30451483-3ECEDBF1-B7D7-47C5-A57B-A423E6CF06E4Q33693726-7FE29FFB-72CB-4816-AD56-D98B943698EBQ33786505-D9AA9760-3C84-4266-9C3B-E112DDFF9819Q33825348-2B22271B-4262-4448-85A7-BAC0686A3276Q33845138-F68A76BD-585D-4394-A8A1-34EEF8ACB4B4Q33912324-21C3A1A8-0440-4D03-AD58-6AD0E9C029B4Q34003779-22D3C627-74EF-401C-BC79-785AE87E0EAFQ34053306-52A41914-A3E4-481C-B95A-C6A9B3E7CB52Q34101451-8D9D89D5-E829-4EA6-A4B4-365AE00DBF16Q34206050-F2B5040C-D03A-44DE-A864-EB37F48B8528Q34209276-B596E7E4-AD6A-4C37-8211-7C3BCCB22373Q34341006-FBF750D8-C6A6-486C-9DE6-5BD8C316E8B3Q34346124-77600AAA-CDFF-43EF-B9CC-A38081C60285Q34382057-9A7033C2-C0DC-4778-AAF7-B48F6C396331Q34415757-D5D33C0D-13CD-4D67-B268-30B7EE475775Q34464043-C5379AD4-3680-4A4E-95E7-E962206AB3CEQ34472336-235C1E3E-C61F-499F-B32E-53D97C2A7A38Q34482952-45ACF7C8-53C9-4BFD-B949-B66C5E1C64CCQ34513032-227E5415-9DB2-4D7B-9238-891F4FF29E1E
P2860
Risk factors and comorbidities in primary biliary cirrhosis: a controlled interview-based study of 1032 patients.
description
2005 nî lūn-bûn
@nan
2005 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Risk factors and comorbidities ...... -based study of 1032 patients.
@ast
Risk factors and comorbidities ...... -based study of 1032 patients.
@en
Risk factors and comorbidities ...... -based study of 1032 patients.
@nl
type
label
Risk factors and comorbidities ...... -based study of 1032 patients.
@ast
Risk factors and comorbidities ...... -based study of 1032 patients.
@en
Risk factors and comorbidities ...... -based study of 1032 patients.
@nl
prefLabel
Risk factors and comorbidities ...... -based study of 1032 patients.
@ast
Risk factors and comorbidities ...... -based study of 1032 patients.
@en
Risk factors and comorbidities ...... -based study of 1032 patients.
@nl
P2093
P2860
P356
P1433
P1476
Risk factors and comorbidities ...... -based study of 1032 patients.
@en
P2093
Ellen B Gold
Howard J Worman
Jessica Utts
John M Vierling
Keith D Lindor
Marshall M Kaplan
Mitchell Watnik
USA PBC Epidemiology Group
P2860
P304
P356
10.1002/HEP.20907
P407
P577
2005-11-01T00:00:00Z